Quantcast

Tag Archives: pfizer

FDA gives Baltimore firm’s drug ‘orphaned’ status

Gliknik Inc., a privately held biopharmaceutical company based in Baltimore, on Monday announced the FDA granted its autoimmune candidate drug GL-2045 orphan drug designation for Chronic Inflammatory Demyelinating Polyneuropathy, a rare neurological disorder characterized by progressive weakness and impaired sensory ...

Read More »

Baltimore biotech Gliknik, Pfizer sign accord

Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.

Read More »